LAMOTRIX

This brand name is authorized in Cyprus, Ecuador, Hong Kong, Poland, Romania, Singapore

Active ingredients

The drug LAMOTRIX contains one active pharmaceutical ingredient (API):

1 Lamotrigine UNII U3H27498KS - LAMOTRIGINE

Lamotrigine is a use and voltage dependent blocker of voltage gated sodium channels. It inhibits sustained repetitive firing of neurons and inhibits release of glutamate (the neurotransmitter which plays a key role in the generation of epileptic seizures). Read about Lamotrigine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LAMOTRIX Tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N03AX09	Lamotrigine	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AX Other antiepileptics
Discover more medicines within N03AX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 369001113, 369011113
Country: HK	Department of Health Drug Office	Identifier(s): 51536, 51537
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100114924, 100114930, 100114947
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W42994001, W42994002, W42994003, W42994004, W42995001, W42995002, W42995003, W42995004, W42996001, W42996002, W42996003, W42996004, W42997001, W42997002, W42997003, W42997004
Country: SG	Health Sciences Authority	Identifier(s): 14027P, 14028P